Active Biotech AB Interim Report January-June 2007

LUND, SWEDEN--(MARKET WIRE)--Aug 9, 2007 -- * Laquinimod: Phase III trials initiated * ANYARA: orphan drug status granted by EMEA * TASQ: Phase I study concluded
MORE ON THIS TOPIC